Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M281 in Adults With Warm Autoimmune Hemolytic Anemia
NCT04119050Phase 3Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2019
- Primary completion
- Feb 2025
- Modality
- Monoclonal Antibodies
- Countries
- 19
01
Overview
A Phase 3 trial of nipocalimab in warm autoimmune hemolytic anemia (wAIHA), sponsored by Janssen Pharmaceutical. Started Aug 2019; status: active, not recruiting.
02
Drugs
nipocalimab
03
Conditions
warm autoimmune hemolytic anemia (wAIHA)
Beyond the preview
Go deeper on NCT04119050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04119050.